Clinical Focus
Business Focus
Spotlight
Subscribe
CE/CME
- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
9 New Drugs for Primary Care: Q1 2020
A first-in-class saliva test for COVID-19 detection, the first oral immunotherapy for peanut allergies, and 7 more new drugs PCPs should know about.
At the close of the first quarter of a new decade, Patient Care® Online has compiled a list of 9 new FDA-approved drugs for conditions that are often seen in primary care. Scroll through the slides below to find details on the first intravenous calcitonin gene-related peptide blocker for migraine prevention; the first and only oral immunotherapy for peanut allergies; a first-in-class collection method that utilizes saliva as the primary test biomaterial for COVID-19; and 6 more.
Related Videos
Related Content
